Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Motor Activity 7Neoplasms 6Breast Neoplasms 3Pancreatic Neoplasms 2Lung Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Fatigue 1Disease 1Colonic Neoplasms 1

Interventions

Letrozole 26Fulvestrant 25Specimen Handling 20ribociclib 17Paclitaxel 16Capecitabine 16pembrolizumab 15palbociclib 15Trastuzumab 14Carboplatin 14exemestane 13abemaciclib 12Tamoxifen 12Anastrozole 12Magnetic Resonance Spectroscopy 11pertuzumab 9trastuzumab deruxtecan 8Biopsy 8Goserelin 7inavolisib 6giredestrant 6elacestrant 6Radiotherapy 6Cyclophosphamide 6130-nm albumin-bound paclitaxel 6patritumab deruxtecan 5eribulin 5Taxes 5Standard of Care 5Gonadotropin-Releasing Hormone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Exercise × 30 days × Clear all
NCT07405385 2026-05-28

REFLEX

University of Castilla-La Mancha

Phase NA Not yet recruiting
44 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT06055803 2026-05-14

Heart Health After Cancer Treatment (HEART-ACT)

University of California, San Francisco

Phase NA Completed
50 enrolled
Breast

Breast Neoplasms

NCT07587957 2026-05-14

Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors

Florida Atlantic University

Phase NA Recruiting
40 enrolled
Breast

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡